Omeprazole induces a long-term clinical remission of protein-losing gastropathy of Ménétrier's disease

Eur J Gastroenterol Hepatol. 1997 Aug;9(8):811-3. doi: 10.1097/00042737-199708000-00014.

Abstract

We report a patient with Ménétrier's disease presenting with extensive subcutaneous oedema, ascites and pleural effusion due to hypoalbuminaemia. Gastric secretory studies showed no free basal and stimulated acid secretion. The gastric juice contained significant amounts of albumin (0.2 g/dl) and immunoglobulin G (IgG) (1.11 mg/dl), corresponding to an estimated daily loss of 9.7 g and 45 mg, respectively. Protein-losing gastropathy was initially unsuccessfully treated with famotidine (80 mg/day) for 17 months, but a long-term (25 months) clinical remission was subsequently achieved with omeprazole (20 mg/day). We suggest that excellent clinical remission of Ménétrier's disease and the associated protein-losing gastropathy may be obtained with long-term omeprazole maintenance treatment, possibly due to Helicobacter pylori suppression.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Albumins / analysis
  • Biopsy
  • Fatal Outcome
  • Gastric Juice / chemistry
  • Gastritis, Hypertrophic / drug therapy*
  • Gastritis, Hypertrophic / pathology
  • Humans
  • Immunoglobulin G / analysis
  • Male
  • Omeprazole / therapeutic use*
  • Protein-Losing Enteropathies / drug therapy*
  • Remission Induction
  • Stomach / pathology

Substances

  • Albumins
  • Immunoglobulin G
  • Omeprazole